NCT03414502 Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response Status RECRUITING Phase PHASE3
NCT03334435 A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT03334422 Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT03334396 A Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT02759731 Study of Baricitinib, a JAK1/2 Inhibitor, in Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Status COMPLETED Phase PHASE1/PHASE2
NCT02758613 A Study of Baricitinib (LY3009104) in Healthy Chinese Participants Status COMPLETED Phase PHASE1
NCT02735707 Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia Status RECRUITING Phase PHASE3
NCT02708095 A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE) Status COMPLETED Phase PHASE2
NCT02576938 A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT02340104 A Study to Measure Baricitinib (LY3009104) Absorption in Healthy Participants Status COMPLETED Phase PHASE1
NCT02265705 A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (RA) Status COMPLETED Phase PHASE3
NCT01968057 A Study of Baricitinib and Ciclosporin in Healthy Participants Status COMPLETED Phase PHASE1
NCT01960140 A Study of Baricitinib and Simvastatin in Healthy Participants Status COMPLETED Phase PHASE1
NCT01937026 A Study of Baricitinib and Probenecid in Healthy Participants Status COMPLETED Phase PHASE1
NCT01925144 A Study of Baricitinib and Omeprazole in Healthy Participants Status COMPLETED Phase PHASE1
NCT01924299 A Study of Baricitinib When Administered With Ketoconazole or Fluconazole in Healthy Participants Status COMPLETED Phase PHASE1
NCT01910311 A Study of Baricitinib and Rifampicin in Healthy Participants Status COMPLETED Phase PHASE1